Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
People
CFOs On the Move: Week Ending March 31
Sysco, Hertz, Upwork, Rolls-Royce, Nikola, FleetCor, Coveo, Cielo
By
Lauren Muskett
| March 31, 2023
Read More
Resources
Reports
Reports
2023
2022
Featured
People
CFOs On the Move: Week Ending March 31
Sysco, Hertz, Upwork, Rolls-Royce, Nikola, FleetCor, Coveo, Cielo
By
Lauren Muskett
| March 31, 2023
Read More
Sign Up
Menu
Reports
2023
2022
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
Sign Up
Sponsored by
FDA
Risk & Compliance
Early Analysis Shows Pfizer COVID-19 Vaccine 90% Effective
The company said 50 million doses of its two-shot vaccine could be available globally by the end of 2020.
By
Lauren Muskett
| November 9, 2020
Read More
Credit & Capital
Akorn Files for Chapter 11 After Failed Takeover
The generic drugmaker listed $10 billion of debt and $10 billion of assets.
By
Lauren Muskett
| May 21, 2020
Read More
Risk & Compliance
SEC Charges Drug Firm with Reg FD Violations
In calls and emails, TherapeuticsMD shared material, nonpublic information about a new drug's likelihood of FDA approval with sell-side analysts.
By
Vincent Ryan
| August 20, 2019
Read More
Investor Relations
Big Health Care Companies Are Undervalued
McKesson and Walgreens are strong, healthy companies, despite recent downturns in their stock prices, a CEO in the investment field says.
By
David McCann
| July 1, 2019
Read More
Risk & Compliance
Is Not Telling the ‘Whole Truth’ Securities Fraud?
A jury verdict that held an ex-CFO liable for misleading investors makes clear that the SEC will take action against incomplete disclosures.
By
Paul Hastings LLP and Nicolas Morgan and Brian Kaewert
| November 27, 2018
Read More
Risk & Compliance
Biotech CFO Accused of Misleading Investors
The ex-CFO of Aveo Pharmaceuticals and other top executives allegedly failed to disclose FDA concerns about an experimental cancer drug.
By
Matthew Heller
| March 30, 2016
Read More
Technology
Health Care: Things are Looking App
Mobile health apps are becoming more capable and potentially rather useful.
By
Economist Staff
| March 14, 2016
Read More
Technology
Taxing Their Patience
The Affordable Care Act's medical-device tax and a proposed Internet sales tax could rile CFOs in 2014.
By
Kathy Hoffelder
| December 6, 2013
Read More
Strategy
The Best Medicines
Merck invests billions in drug R&spamp;D every year, and it&spamp;rsquo;s up to CFO Peter Kellogg to ensure that the money is spent wisely.
By
Edward Teach
| March 21, 2013
Read More
Human Capital & Careers
Alternative Health Benefits: “Like Bringing Your Pet to Work”?
Despite one manufacturer’s staunch insistence that its broad coverage of alternative medicine practices yields big benefits, skeptics abound.
By
David McCann
| October 31, 2012
Read More